Roche Advances Next-Generation Sequencing in Asia Pacific with AXELIOS 1 Launch
Roche is expanding its next-generation sequencing (NGS) initiatives in the Asia Pacific region following the global introduction of its AXELIOS 1 platform in June 2026. Building on initial adoption in South Korea, Roche plans to bring this advanced technology closer to researchers and laboratory leaders through 'AXELIOS Days' events scheduled for November in Sydney, Australia, and Seoul, South Korea. The AXELIOS 1 platform utilizes Roche's proprietary sequencing by expansion (SBX) technology, which is designed to offer flexibility and high performance across various sequencing workflows. This technology converts genetic information into synthetic molecules called Xpandomers, which are approximately 50 times longer than original DNA fragments, enhancing sequencing accuracy. The platform also boasts high-speed processing, capable of completing sequencing runs in approximately 15 minutes to four hours and generating at least 1.8 terabases in a four-hour run, with the potential for same-day whole-genome sequen...
